HealthEdge Announces Technology Assessment Program for Payors with Legacy Core Administrative Platforms
<0> Racepoint GroupPJ Lurvey, 617-624-3210 </0>
® today announced that it is offering a free technology assessment program aimed at helping health plans that use discontinued and outdated core administrative platforms. The assessment will provide a platform neutral roadmap that will guide organizations in the transition to a modern technology platform.
“Real change is needed inside payor organizations to keep pace with market and regulatory changes,” said HealthEdge Chief Executive Officer Rob Gillette. “Many plans still struggle with outdated or unsupported legacy systems that are not able to address their business goals. Payors that take advantage of HealthEdge’s assessment program will discover how they can reduce costs and immediately support new standards like ICD-10 and emerging healthcare business models.”
The HealthEdge assessment program begins with a full, complimentary evaluation of the payor’s existing infrastructure, including their core administrative system and any satellite systems, custom databases, and reporting solutions that are present in the organization. This information is used to provide a customized transition roadmap that the payor can follow to move from their existing technology to a modern platform.
More information on the HealthRules assessment program can be found at . Questions can be emailed to .
HealthEdge® provides the only modern, enterprise-class software platform for healthcare payors. Using the patented HealthRules® software suite, health plans, health insurance companies, and other payors can finally respond to new business opportunities and market changes in hours, not months or years, while drastically reducing both IT and operational costs. Leveraging an investment of over $150 million, HealthRules is the most modern, scalable, and cost-effective technology in the industry. HealthEdge is the only choice for payors to survive and thrive in the emerging healthcare economy. For more information, visit .